Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionBBSC - JPMorgan BetaBuilders U.S. Small Cap Equity ETF
Latest Disclosed Ownership44,113 shares
Latest Disclosed Value $ 1,240,898
BBSC - JPMorgan BetaBuilders U.S. Small Cap Equity ETF reports 2.40% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 26, 2026 - BBSC - JPMorgan BetaBuilders U.S. Small Cap Equity ETF filed a NPORT-P form disclosing ownership of 44,113 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,240,899 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 43,078 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 2.40% during the quarter. The current value of the position is $1,389,118 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 44,113 1,035 2.40 1,241 18.55 0.1695
2026-03-27 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 43,078 4,457 11.54 1,047 27.41 0.1572
2025-12-29 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 38,621 -2,101 -5.16 821 -5.41 0.1396
2025-09-25 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 40,722 4,292 11.78 869 -1.81 0.1562
2025-06-24 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 36,430 3,767 11.53 885 20.11 0.1825
2025-03-28 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 32,663 -2,900 -8.15 737 -5.03 0.1419
2024-12-26 2024-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 35,563 -1,418 -3.83 775 21.66 0.1496
2024-09-26 2024-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 36,981 2,873 8.42 638 24.17 0.1155
2024-06-27 2024-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 34,108 -28,496 -45.52 513 -43.06 0.1142
2024-03-28 2024-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 62,604 7,503 13.62 901 31.92 0.1106
2023-12-21 2023-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 55,101 -5,302 -8.78 684 -18.20 0.1096
2023-09-28 2023-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 60,403 6,881 12.86 835 -2.00 0.0977
2023-06-27 2023-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 53,522 11,905 28.61 852 32.30 0.1224
2023-03-27 2023-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 41,617 41,617 645 0.1083
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.